Radiotherapy With Pembrolizumab in Metastatic HNSCC

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Combination Product: A (pembrolizumab+RT);   Drug: B (pembrolizumab)
Sponsor:   University of Erlangen-Nürnberg Medical School
Not yet recruiting

http://ift.tt/2lj4YcS